Jacobi F, Wittchen H-U, Holting C, Höfler M, Pfister H, Müller N, Lieb R
Institute of Clinical Psychology and Psychotherapy, Unit: Epidemiology and Service Research, Technical University of Dresden, Germany.
Psychol Med. 2004 May;34(4):597-611. doi: 10.1017/S0033291703001399.
The German National Health Interview and Examination Survey (GHS) is the first government mandated nationwide study to investigate jointly the prevalence of somatic and mental disorders within one study in the general adult population in Germany. This paper reports results from its Mental Health Supplement (GHS-MHS) on 4-week 12-month, and selected lifetime prevalence of a broad range of DSM-IV mental disorders, their co-morbidity and correlates in the community.
The sample of the GHS-MHS (n=4181; multistage stratified random sample drawn from population registries; conditional response rate: 87.6%) can be regarded as representative for the German population aged 18-65. Diagnoses are based on fully structured computer assisted clinical interviews (M-CIDI), conducted by clinically trained interviewers.
12-month prevalence for any DSM-IV study disorder is 31% (lifetime: 43%; 4-week: 20%) with anxiety disorders, mood disorders and somatoform syndromes being the most frequent diagnoses. Retrospective age of onset information reveals that most disorders begin early in life. Co-morbidity rates among mental disorders range from 44% to 94%. Correlates of increased rates of mental disorders and co-morbidity were: female gender (except for substance disorders), not being married, low social class, and poor somatic health status. Health care utilization for mental disorders depended on co-morbidity (30% in 'pure', 76% in highly co-morbid cases) and varied from 33% for substance use disorders to 75% for panic disorder.
Results confirm and extend results from other national studies using the same assessment instruments with regard to prevalence, co-morbidity and sociodemographic correlates, covering a broader range of DSM-IV disorders [i.e. somatoform disorders, all anxiety disorders (except PTSD), mental disorders due to substance or general medical factor, eating disorders]. Intervention rates were higher than in previous studies, yet still low overall.
德国国民健康访谈与检查调查(GHS)是德国政府委托开展的第一项全国性研究,旨在在一项研究中联合调查德国普通成年人群中躯体疾病和精神障碍的患病率。本文报告了其心理健康补充调查(GHS-MHS)关于4周、12个月以及一系列广泛的DSM-IV精神障碍的特定终生患病率、共病情况及其在社区中的相关因素的结果。
GHS-MHS的样本(n = 4181;从人口登记处抽取的多阶段分层随机样本;条件应答率:87.6%)可被视为德国18至65岁人群的代表性样本。诊断基于由经过临床培训的访谈员进行的完全结构化的计算机辅助临床访谈(M-CIDI)。
任何DSM-IV研究障碍的12个月患病率为31%(终生患病率:43%;4周患病率:20%),焦虑障碍、心境障碍和躯体形式综合征是最常见的诊断。回顾性发病年龄信息显示,大多数障碍在生命早期开始。精神障碍之间的共病率在44%至94%之间。精神障碍和共病率增加的相关因素包括:女性(物质使用障碍除外)、未婚、社会阶层低以及躯体健康状况差。精神障碍的医疗保健利用率取决于共病情况(“单纯”病例中为30%,高度共病病例中为76%),范围从物质使用障碍的33%到惊恐障碍的75%不等。
结果证实并扩展了其他使用相同评估工具的全国性研究在患病率、共病情况和社会人口学相关因素方面的结果,涵盖了更广泛的DSM-IV障碍[即躯体形式障碍、所有焦虑障碍(创伤后应激障碍除外)、物质或一般医学因素所致精神障碍、进食障碍]。干预率高于先前研究,但总体上仍然较低。